Patient Acceptance of Whole Body Magnetic Resonance Angiography

Atherosclerosis Clinical Trial

Official title:

Whole Body Magnetic Resonance Angiography: Questionnaire Examination of Patient Acceptance.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00556101
• Other study ID #: WB-angio herlev 4
• Status: Completed
• Phase: N/A
• First received: November 8, 2007
• Last updated: August 18, 2009
• Start date: November 2007
• Est. completion date: July 2009

Study information

• Verified date: August 2009
• Source: Copenhagen University Hospital at Herlev
• Contact: n/a
• Is FDA regulated: No
• Health authority: Denmark: National Board of Health
• Study type: Observational

Clinical Trial Summary

Investigation of how the patients experience whole body MRA. After the WB-MRA the patients will fill in a questionnaire, that contains questions about the WB-MRA procedure and how the patient felt during the examination.

We expect that the patients will report a high degree of satisfaction with the WB-MRA procedure, with little discomfort.

Description:

WB-MRA is performed in patients referred for conventional x-ray based angiography. The WB-MRA is performed first in all patients.

After both examinations are completed the patients will be asked to fill in a questionnaire containing questions about their experience of the 2 procedures.

We will then compare the results for the procedures.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 81
• Est. completion date: July 2009
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Symptomatic lower extremity ischemia (claudication, ischemic wounds)

• Referred to digital subtraction angiography (DSA)

Exclusion Criteria:

• Renal insufficiency (GFR < 30 ml/min)

• Contra-indications for MRI-examination (claustrophobia, metal-implants, pacemaker)

• Dementia

• Pregnancy/lactation

• Allergy to gadolinium based MRI contrast agents

• Acute disease

Study Design

Time Perspective: Prospective

Related Conditions & MeSH terms

• Atherosclerosis
• Intermittent Claudication
• MRI

Intervention

Procedure:
• Whole body magnetic resonance angiography

Locations

Country	Name	City	State
Denmark	Department of Radiology, Herlev University Hospital	Herlev Copenhagen	Herlev

Sponsors (2)

Lead Sponsor	Collaborator
Copenhagen University Hospital at Herlev	Rigshospitalet, Denmark

Country where clinical trial is conducted

Denmark, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Patient acceptance of Whole body MRA